Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quality of life after switching to insulin glargine in Type 2 diabetes
2005-000959-15Phase 4Completed
- Sponsor
- Sanofi
- Start
- Mar 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of insulin glargine in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Primary endpoint: Diabetes Treatment Satisfaction Questionnaire (DTSQ). Started Mar 2005; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2005-000959-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000959-15.